| 000 | 01527 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517061825.0 | ||
| 264 | 0 | _c20160425 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1759-4782 | ||
| 024 | 7 |
_a10.1038/nrclinonc.2015.187 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBatlevi, Connie Lee | |
| 245 | 0 | 0 |
_aNovel immunotherapies in lymphoid malignancies. _h[electronic resource] |
| 260 |
_bNature reviews. Clinical oncology _cJan 2016 |
||
| 300 |
_a25-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Bispecific _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aBrentuximab Vedotin |
| 650 | 0 | 4 |
_aHodgkin Disease _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoconjugates _xtherapeutic use |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 | _aNivolumab |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 |
_aRituximab _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMatsuki, Eri | |
| 700 | 1 | _aBrentjens, Renier J | |
| 700 | 1 | _aYounes, Anas | |
| 773 | 0 |
_tNature reviews. Clinical oncology _gvol. 13 _gno. 1 _gp. 25-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nrclinonc.2015.187 _zAvailable from publisher's website |
| 999 |
_c25410851 _d25410851 |
||